JP2018150331A5 - - Google Patents

Download PDF

Info

Publication number
JP2018150331A5
JP2018150331A5 JP2018088646A JP2018088646A JP2018150331A5 JP 2018150331 A5 JP2018150331 A5 JP 2018150331A5 JP 2018088646 A JP2018088646 A JP 2018088646A JP 2018088646 A JP2018088646 A JP 2018088646A JP 2018150331 A5 JP2018150331 A5 JP 2018150331A5
Authority
JP
Japan
Prior art keywords
disease
compound according
pharmaceutically acceptable
acceptable salt
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018088646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018150331A (ja
JP6654659B2 (ja
Filing date
Publication date
Priority claimed from US13/843,261 external-priority patent/US8957066B2/en
Application filed filed Critical
Publication of JP2018150331A publication Critical patent/JP2018150331A/ja
Publication of JP2018150331A5 publication Critical patent/JP2018150331A5/ja
Application granted granted Critical
Publication of JP6654659B2 publication Critical patent/JP6654659B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018088646A 2013-03-15 2018-05-02 ヒストン脱アセチル化酵素阻害剤 Expired - Fee Related JP6654659B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/843,261 2013-03-15
US13/843,261 US8957066B2 (en) 2011-02-28 2013-03-15 Histone deacetylase inhibitors

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016502408A Division JP6336562B2 (ja) 2013-03-15 2014-03-14 ヒストン脱アセチル化酵素阻害剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019188049A Division JP2020019814A (ja) 2013-03-15 2019-10-11 ヒストン脱アセチル化酵素阻害剤

Publications (3)

Publication Number Publication Date
JP2018150331A JP2018150331A (ja) 2018-09-27
JP2018150331A5 true JP2018150331A5 (enExample) 2018-12-13
JP6654659B2 JP6654659B2 (ja) 2020-02-26

Family

ID=49622075

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016502408A Expired - Fee Related JP6336562B2 (ja) 2013-03-15 2014-03-14 ヒストン脱アセチル化酵素阻害剤
JP2018088646A Expired - Fee Related JP6654659B2 (ja) 2013-03-15 2018-05-02 ヒストン脱アセチル化酵素阻害剤
JP2019188049A Pending JP2020019814A (ja) 2013-03-15 2019-10-11 ヒストン脱アセチル化酵素阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016502408A Expired - Fee Related JP6336562B2 (ja) 2013-03-15 2014-03-14 ヒストン脱アセチル化酵素阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019188049A Pending JP2020019814A (ja) 2013-03-15 2019-10-11 ヒストン脱アセチル化酵素阻害剤

Country Status (15)

Country Link
US (6) US8957066B2 (enExample)
EP (2) EP2968251B1 (enExample)
JP (3) JP6336562B2 (enExample)
KR (1) KR20150132342A (enExample)
CN (2) CN105120860B (enExample)
AU (1) AU2014239677B2 (enExample)
BR (1) BR112015023434A8 (enExample)
CA (2) CA3105007A1 (enExample)
DK (1) DK2968251T3 (enExample)
ES (1) ES2780693T3 (enExample)
IL (3) IL240938B (enExample)
MX (2) MX375260B (enExample)
PT (1) PT2968251T (enExample)
RU (1) RU2673819C2 (enExample)
WO (1) WO2014152444A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735593C (en) 2008-09-03 2017-08-15 Repligen Corporation Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP3524324A1 (en) * 2011-02-28 2019-08-14 BioMarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) * 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP2701699B1 (en) 2011-04-28 2019-10-16 The Broad Institute, Inc. Inhibitors of histone deacetylase
JP6337255B2 (ja) 2012-07-27 2018-06-06 ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. ヒストンデアセチラーゼの阻害剤
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
US10029988B2 (en) 2013-03-15 2018-07-24 Biomarin Pharmaceutical Inc. HDAC inhibitors
US9988343B2 (en) * 2013-11-05 2018-06-05 Dana-Farber Cancer Institute, Inc. Inhibitors of histone deacetylase
US10851058B2 (en) * 2015-07-02 2020-12-01 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2017075418A1 (en) 2015-10-30 2017-05-04 Board Of Trustees Of The University Of Arkansas Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof
TW201829381A (zh) * 2016-12-22 2018-08-16 美商拜奧馬林製藥公司 組蛋白脫乙醯基酶抑制劑
EA039417B1 (ru) * 2017-08-07 2022-01-25 Родин Терапеутикс, Инк. Бициклические ингибиторы гистондеацетилазы
EP3664789B1 (en) * 2017-08-09 2023-11-22 Children's Hospital Medical Center Methods for treating diseases and nerve injury
US12128018B2 (en) 2018-01-12 2024-10-29 KDAc Therapeutics, Inc. Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer
WO2020029980A1 (en) 2018-08-06 2020-02-13 Moexa Pharmaceuticals Limited Smad3 inhibitors
GB201901559D0 (en) * 2019-02-05 2019-03-27 Syngenta Crop Protection Ag Herbicidal compositions
KR20220070465A (ko) 2019-09-27 2022-05-31 다케다 야쿠힌 고교 가부시키가이샤 Hdac6 억제제로서 유용한 2-이소인돌-1,3,4-옥사디아졸 유도체

Family Cites Families (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174958A (en) * 1978-01-09 1979-11-20 Shell Oil Company Anilide derivative herbicides
US4855442A (en) 1988-04-13 1989-08-08 Monsanto Company Substituted 3-hydroxy pyrazoles
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US6794392B1 (en) 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
JPH11269140A (ja) 1998-03-23 1999-10-05 Mitsui Chem Inc 分化誘導剤
JPH11269146A (ja) 1998-03-24 1999-10-05 Mitsui Chem Inc 分化誘導剤
JP4405602B2 (ja) 1998-04-16 2010-01-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ヒストン脱アセチル化酵素阻害剤
EP1140834A1 (en) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Heterocyclic piperidines as modulators of chemokine receptor activity
JP2000256194A (ja) 1999-01-06 2000-09-19 Mitsui Chemicals Inc 核内レセプタ作動薬およびその効果増強剤
WO2000061557A1 (en) 1999-04-09 2000-10-19 Mochida Pharmaceutical Co., Ltd. 4-hydroxypiperidine derivatives having antiarrhythmic effect
JP2001072592A (ja) * 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
EP1233958B1 (en) 1999-11-23 2011-06-29 MethylGene Inc. Inhibitors of histone deacetylase
AU2001280187A1 (en) 2000-08-28 2002-03-13 Toray Industries, Inc. Cyclic amine derivatives
GB0021419D0 (en) * 2000-08-31 2000-10-18 Oxford Glycosciences Uk Ltd Compounds
AU2002211281A1 (en) * 2000-09-29 2002-04-08 Millenium Pharmaceuticals, Inc. Quaternary amidino based inhibitors of factor xa
WO2002090534A1 (en) 2001-05-02 2002-11-14 The Regents Of The University Of California Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors
US20040142859A1 (en) 2002-05-02 2004-07-22 Steffan Joan S. Method for treating neurodegenerative, psychiatric, and other disorders with deacetylase inhibitors
US6784173B2 (en) 2001-06-15 2004-08-31 Hoffmann-La Roche Inc. Aromatic dicarboxylic acid derivatives
AR034897A1 (es) 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
US6806272B2 (en) 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
JP3795044B2 (ja) 2001-09-14 2006-07-12 メシルジーン、インコーポレイテッド ヒストンデアセチラーゼの阻害剤
US6897220B2 (en) 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
ATE383245T1 (de) 2001-09-27 2008-01-15 Api Corp Entwickler für wärmeaufzeichnungsmaterial und wärmeaufzeichnungsmaterialien
JP2003137866A (ja) 2001-11-01 2003-05-14 Sankyo Co Ltd フェニレンジアミン誘導体
MXPA04007775A (es) 2002-03-13 2004-10-15 Janssen Pharmaceutica Nv Derivados de sulfonilo como novedosos inhibidores de la histona desacetilasa.
TWI319387B (en) 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
GB0209715D0 (en) 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
US20040072770A1 (en) 2002-07-03 2004-04-15 Besterman Jeffrey M. Methods for specifically inhibiting histone deacetylase-7 and 8
JP2004035485A (ja) 2002-07-04 2004-02-05 Mitsui Chemicals Inc テロメラーゼ阻害剤
US20050215601A1 (en) 2002-09-25 2005-09-29 Santen Pharmaceutical Co., Ltd. Therapeutic agent for rheumatic disease comprising benzamide derivative as active ingredient
KR20050074487A (ko) 2002-10-17 2005-07-18 메틸진, 인크. 히스톤 데아세틸라아제의 억제제
US7265129B2 (en) 2002-10-25 2007-09-04 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
US6852748B1 (en) 2002-10-30 2005-02-08 Boehringer Ingelheim Pharmaceuticals, Inc. Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
TW200426138A (en) 2002-12-10 2004-12-01 Hoffmann La Roche Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives, their manufacture and use as pharmaceutical agents
JP2006514991A (ja) 2002-12-27 2006-05-18 シエーリング アクチエンゲゼルシャフト 新規医薬組合せ
US7208491B2 (en) 2003-02-07 2007-04-24 Hoffmann-La Roche Inc. N-monoacylated o-phenylenediamines
CA2515215A1 (en) 2003-02-10 2004-08-26 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7244751B2 (en) 2003-02-14 2007-07-17 Shenzhen Chipscreen Biosciences Ltd. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
US7030112B2 (en) 2003-03-25 2006-04-18 Bristol-Myers Squibb Company Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
TW200424187A (en) 2003-04-04 2004-11-16 Hoffmann La Roche New oxime derivatives and their use as pharmaceutically active agents
GB0315203D0 (en) 2003-06-28 2003-08-06 Celltech R&D Ltd Chemical compounds
TWI372050B (en) 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
PT1658263E (pt) 2003-07-24 2010-09-06 Leo Pharma As Novos compostos de aminobenzofenona
WO2005026127A1 (ja) * 2003-09-11 2005-03-24 Institute Of Medicinal Molecular Design. Inc. プラスミノゲンアクチベータインヒビター－１阻害剤
WO2005030704A1 (en) 2003-09-24 2005-04-07 Methylgene, Inc. Inhibitors of histone deacetylase
US7141596B2 (en) 2003-10-08 2006-11-28 Incyte Corporation Inhibitors of proteins that bind phosphorylated molecules
AU2004296764B2 (en) 2003-12-02 2011-04-28 The Ohio State University Research Foundation Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
EP1541549A1 (en) 2003-12-12 2005-06-15 Exonhit Therapeutics S.A. Tricyclic hydroxamate and benzaminde derivatives, compositions and methods
DK1702917T3 (da) * 2003-12-25 2017-11-13 Nippon Shinyaku Co Ltd Amidderivat og medicin
PL1725528T3 (pl) 2004-03-11 2013-12-31 4Sc Ag Sulfonylopirole jako inhibitory HDAC
JP5168711B2 (ja) 2004-03-25 2013-03-27 アステラス製薬株式会社 ソリフェナシンまたはその塩の固形製剤用組成物
WO2005092899A1 (en) 2004-03-26 2005-10-06 Methylgene Inc. Inhibitors of histone deacetylase
US7253204B2 (en) * 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
WO2006001958A2 (en) 2004-05-21 2006-01-05 Merck & Co., Inc. Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
US20080234254A1 (en) 2004-06-10 2008-09-25 University Of Leeds Inhibitors of Histone Deacetylase
EP1768956A1 (en) 2004-07-12 2007-04-04 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Amide derivatives as inhibitors of histone deacetylase
EP1773330B1 (en) 2004-07-22 2010-05-26 Merck Sharp & Dohme Corp. Substituted pyrazoles, compositions containing such compounds and methods of use
WO2006033943A2 (en) 2004-09-17 2006-03-30 Exelixis, Inc Pyrazole kinase modulators and methods of use
CN101080389A (zh) 2004-10-15 2007-11-28 拜尔药品公司 具有抗增殖活性的茚满酰胺
CN100349070C (zh) 2004-11-25 2007-11-14 同济大学 一种偶氮/酞菁复合单层有机光电导体及其制备方法
EP1828186A1 (en) 2004-12-13 2007-09-05 Sunesis Pharmaceuticals, Inc. Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
WO2006066133A2 (en) 2004-12-16 2006-06-22 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1836199A1 (en) 2004-12-30 2007-09-26 Astex Therapeutics Limited Thiazole and isothiazole derivatives that modulate the activity of cdk, gsk and aurora kinases
CA2599538C (en) 2005-03-15 2013-07-30 Nycomed Gmbh N-sulphonylpyrroles and their use as histone deacetylase inhibitors
US20060223807A1 (en) 2005-03-29 2006-10-05 University Of Massachusetts Medical School, A Massachusetts Corporation Therapeutic methods for type I diabetes
WO2006102760A1 (en) 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase
CA2603398A1 (en) 2005-04-07 2006-10-12 Nycomed Gmbh Sulfonylpyrroles as histone deacetylase inhibitors
AU2006240258A1 (en) 2005-04-20 2006-11-02 Merck Sharp & Dohme Corp. Benzothiophene derivatives
US7642253B2 (en) 2005-05-11 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP4528918B2 (ja) 2005-06-21 2010-08-25 学校法人 関西大学 カルボキサミド誘導体
EP1896395B1 (en) 2005-06-24 2015-07-15 Merck Sharp & Dohme Corp. Modified malonate derivatives
KR20080032188A (ko) 2005-07-14 2008-04-14 다케다 샌디에고, 인코포레이티드 히스톤 탈아세틸화 효소 억제제
JP2009509923A (ja) 2005-08-26 2009-03-12 メシルジーン、インコーポレイテッド ヒストンデアセチラーゼのベンゾジアゼピン及びベンゾピペラジン類似体阻害薬
AU2006284751A1 (en) 2005-09-01 2007-03-08 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
ES2381962T3 (es) 2005-09-21 2012-06-04 4Sc Ag Nuevos sulfonilpirroles como inhibidores de las HDAC
AU2006298881A1 (en) 2005-09-21 2007-04-12 4Sc Ag Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
EA200801025A1 (ru) 2005-10-06 2008-12-30 Юниверсити Оф Массачусетс Композиция и синтез новых реагентов для ингибирования репликации вич
GB0521244D0 (en) * 2005-10-19 2005-11-30 Astrazeneca Ab Benzamide compounds
WO2007055942A2 (en) 2005-11-03 2007-05-18 Merck & Co., Inc. Substituted nicotinamide compounds
JP2009515887A (ja) 2005-11-11 2009-04-16 ザ スクリプス リサーチ インスティテュート 神経系疾患のための治療薬としてのヒストンデアセチラーゼ阻害剤
AR057579A1 (es) 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
CA2635209A1 (en) 2006-01-12 2007-08-02 Merck & Co., Inc. Fluorinated arylamide derivatives
AU2007208495A1 (en) 2006-01-12 2007-08-02 Merck Sharp & Dohme Corp. Hydroxyalkylarylamide derivatives
EP1976835A2 (en) 2006-01-13 2008-10-08 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7834025B2 (en) 2006-01-19 2010-11-16 Janssen Pharmaceutica N.V. Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
JP5247470B2 (ja) 2006-01-19 2013-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
CN101370789B (zh) 2006-01-19 2012-05-30 詹森药业有限公司 作为组蛋白脱乙酰酶抑制剂的吡啶和嘧啶衍生物
WO2007082878A1 (en) 2006-01-19 2007-07-26 Janssen Pharmaceutica N.V. Aminophenyl derivatives as novel inhibitors of histone deacetylase
US7834011B2 (en) 2006-01-19 2010-11-16 Janssen Pharmaceutica N.V. Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
AU2007221207A1 (en) 2006-02-28 2007-09-07 Merck Sharp & Dohme Corp. Inhibitors of histone deacetylase
GB0606876D0 (en) 2006-04-05 2006-05-17 Glaxo Group Ltd Compounds
WO2007118137A1 (en) 2006-04-07 2007-10-18 Methylgene Inc. Benzamide derivatives as inhibitors of histone deacetylase
CA2651681A1 (en) 2006-05-18 2007-11-29 Merck & Co., Inc. Aryl-fused spirocyclic compounds
GB0614070D0 (en) 2006-07-14 2006-08-23 Glaxo Group Ltd Compounds
CA2657288A1 (en) 2006-07-20 2008-01-24 Merck & Co., Inc. Phosphorus derivatives as histone deacetylase inhibitors
WO2008019025A2 (en) 2006-08-03 2008-02-14 Georgetown University Isoform-selective hdac inhibitors
CA2662937A1 (en) 2006-09-11 2008-03-20 Curis, Inc. Multi-functional small molecules as anti-proliferative agents
AU2007296740B2 (en) 2006-09-11 2012-09-27 Curis, Inc. Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety
DK2066327T3 (da) * 2006-09-15 2013-02-11 Janssen Pharmaceutica Nv Histondeacetylaseinhibitorer med kombineret aktivitet mod klassse I- og klasse IIB-histondeacetylaser i kombination med proteasominihibitorer
CA2672192A1 (en) 2006-12-19 2008-06-26 Methylgene Inc. Inhibitors of histone deacetylase and prodrugs thereof
WO2008078762A1 (ja) 2006-12-26 2008-07-03 Santen Pharmaceutical Co., Ltd. ウレア構造を有する新規ｎ－(２－アミノフェニル)ベンズアミド誘導体
WO2008084218A1 (en) 2007-01-12 2008-07-17 Boehringer Ingelheim International Gmbh Benzazole derivatives for the treatment of inflammations
WO2008089436A2 (en) 2007-01-18 2008-07-24 Takeda San Diego, Inc. Crystalline forms of histone deacetylase inhibitors
US8030344B2 (en) 2007-03-13 2011-10-04 Methylgene Inc. Inhibitors of histone deacetylase
JP5577104B2 (ja) 2007-03-14 2014-08-20 エクセリクシス パテント カンパニー エルエルシー ヘッジホッグ経路の阻害剤
CN101730703B (zh) 2007-03-16 2012-12-26 中国人民解放军军事医学科学院放射与辐射医学研究所 具有抗增殖活性的苯甲酰胺类衍生物及其药用制剂
WO2008123395A1 (ja) 2007-03-28 2008-10-16 Santen Pharmaceutical Co., Ltd. ヒストン脱アセチル化酵素阻害作用を有する化合物を有効成分として含有する眼圧下降剤
US8012972B2 (en) 2007-03-28 2011-09-06 Santen Pharmaceutical Co., Ltd. Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
US9096565B2 (en) 2007-04-09 2015-08-04 Methylgene Inc. Inhibitors of histone deacetylase
WO2009002534A1 (en) 2007-06-26 2008-12-31 Gilead Colorado, Inc. Imidazopyridinyl thiazolyl histone deacetylase inhibitors
US8389553B2 (en) 2007-06-27 2013-03-05 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
ES2609258T3 (es) 2007-06-29 2017-04-19 Pfizer Inc. Derivados de bencimidazol
US20100267779A1 (en) 2007-07-23 2010-10-21 Syndax Pharmaceuticals, Inc. Novel Compounds and Methods of Using Them
CA2694297A1 (en) 2007-08-09 2009-02-12 Merck Sharp & Dohme Corp. Silicon derivatives as histone deacetylase inhibitors
WO2009024825A1 (en) 2007-08-21 2009-02-26 Astrazeneca Ab 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors
US20120004222A1 (en) 2007-08-21 2012-01-05 Zhicai Wu Cb2 receptor ligands for the treatment of pain
TW200918521A (en) 2007-08-31 2009-05-01 Astrazeneca Ab Heterocyclic amides and methods of use thereof
WO2009036057A1 (en) 2007-09-10 2009-03-19 Curis, Inc. Antiproliferative agents containing a zinc binding moiety
CN101861151B (zh) 2007-09-14 2014-08-13 梅特希尔基因公司 使用组蛋白脱乙酰基酶hdac1、hdac2和/或hdac3的选择性抑制剂和微管稳定剂的癌症组合治疗
AU2008300827B2 (en) 2007-09-19 2013-04-04 4Sc Ag Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
ES2628748T3 (es) 2007-10-01 2017-08-03 Lixte Biotechnology, Inc. Inhibidores de la HDAC
MX2010004402A (es) 2007-10-22 2010-10-15 Orchid Res Lab Ltd Inhibidores de histona deacetilasa.
EP2060565A1 (en) 2007-11-16 2009-05-20 4Sc Ag Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
EP2220066A1 (en) 2007-12-14 2010-08-25 Gilead Colorado, Inc. Benzofuran anilide histone deacetylase inhibitors
WO2009086012A1 (en) 2007-12-20 2009-07-09 Curis, Inc. Aurora inhibitors containing a zinc binding moiety
EP2100882A1 (en) 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts
MX2010014572A (es) 2008-06-27 2011-03-24 Novartis Ag Compuestos organicos.
WO2010009139A2 (en) 2008-07-14 2010-01-21 Gilead Colorado, Inc. Imidazolyl pyrimidine inhibitor compounds
NZ602832A (en) 2008-07-14 2014-04-30 Gilead Sciences Inc Fused heterocyclic hdac inhibitor compounds
CA2728228A1 (en) 2008-07-14 2010-01-21 Gilead Sciences, Inc. Oxindolyl inhibitor compounds
MX2011001090A (es) 2008-07-28 2011-03-15 Gilead Sciences Inc Compuestos de inhibidor de desacetilasa de histona de cicloalquilideno y heterocicloalquilideno.
CA2735593C (en) 2008-09-03 2017-08-15 Repligen Corporation Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
US8283358B2 (en) 2008-09-05 2012-10-09 Elan Pharmaceuticals, Inc. N-sulfonamido polycyclic pyrazolyl compounds
US8202866B2 (en) 2008-09-17 2012-06-19 Hoffmann-La Roche Inc. Ortho-aminoanilides for the treatment of cancer
UY32158A (es) 2008-10-03 2010-04-30 Astrazeneca Ab Derivados heterociclicos y metodos de uso de los mismos
WO2010043953A2 (en) 2008-10-15 2010-04-22 Orchid Research Laboratories Ltd. Novel bridged cyclic compounds as histone deacetylase inhibitors
PL2349245T3 (pl) 2008-10-29 2017-07-31 Istituto Superiore di Sanità Leczenie utajonego zakażenia wirusem hiv-1 za pomocą auranofiny lub tritlenku diarsenu
WO2010094678A1 (en) 2009-02-23 2010-08-26 F. Hoffmann-La Roche Ag Novel ortho-aminoamides for the treatment of cancer
KR101145345B1 (ko) 2009-04-24 2012-07-09 계명대학교 산학협력단 세포증식 억제제로서 유용한 2-싸이오-4-아미노 피리미딘 유도체 및 그 제조방법
US8362249B2 (en) 2009-04-27 2013-01-29 Boehringer Ingelheim International Gmbh CXCR3 receptor antagonists
EP2424840B1 (en) 2009-04-27 2014-08-06 Boehringer Ingelheim International GmbH Cxcr3 receptor antagonists
WO2010127152A2 (en) 2009-04-29 2010-11-04 Irm Llc Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
EP2429987A4 (en) 2009-05-15 2012-10-03 Korea Res Inst Chem Tech AMIDE COMPOUND, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
US8211901B2 (en) 2009-05-22 2012-07-03 Shenzhen Chipscreen Biosciences Ltd. Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
WO2010144371A1 (en) 2009-06-08 2010-12-16 Gilead Colorado, Inc. Alkanoylamino benzamide aniline hdac inihibitor compounds
ES2463826T3 (es) 2009-06-08 2014-05-29 Gilead Sciences, Inc. Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina
CN101648922B (zh) 2009-08-20 2011-08-31 苏州东南药物研发有限责任公司 苯甲酰胺类组蛋白去乙酰酶抑制剂及其用途
EP2598133A4 (en) 2010-07-30 2014-03-05 Univ California METHOD AND THERAPEUTIC FOR TREATING AND CONTROLLING MEMBERSHIP EDUCATION
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP3524324A1 (en) 2011-02-28 2019-08-14 BioMarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP2734164A4 (en) 2011-07-21 2015-04-22 Kt Health Llc KNEIOLOGY TAPE PREEDECOUPÉS
TWI573792B (zh) * 2012-02-01 2017-03-11 歐陸斯迪公司 新穎治療劑

Similar Documents

Publication Publication Date Title
JP2018150331A5 (enExample)
JP2014500861A5 (enExample)
JP2019038829A5 (enExample)
JP2016040288A5 (enExample)
JP2017533968A5 (enExample)
JP2013514980A5 (enExample)
JP2011526924A5 (enExample)
JP2018135343A5 (enExample)
RU2015143843A (ru) Ингибиторы гистондеацетилазы
JP2018158926A5 (enExample)
JP2013541514A5 (enExample)
JP2011500638A5 (enExample)
JP2017535586A5 (enExample)
JP2017504653A5 (enExample)
JP2016537338A5 (enExample)
JP2018537535A5 (enExample)
JP2012504133A5 (enExample)
JP2011507896A5 (enExample)
JP2017538773A5 (enExample)
JP2010504343A5 (enExample)
JP2015523546A5 (enExample)
JP2018538273A5 (enExample)
JP2012502111A5 (enExample)
JP2018525342A5 (enExample)
JP2017521364A5 (enExample)